GENinCode

GENinCode provides genomic testing for the prevention, diagnosis, and treatment of cardiovascular disease. Harnessing the power of both monogenic and polygenic risk assessment to combat the world’s most prevalent health problem. GENinCode tests provide patients and physicians with globally leading risk assessment tools to inform cardiovascular preventive care and treatment. Our technologies combine monogenic, polygenic and clinical information to provide advanced patient risk assessment to predict and prevent cardiovascular disease.